ºñÁê¾ó
Publications

Research Papers

°Ô½ÃÆÇ º¸±â
ÀÛ¼ºÀÚ ÀÛ¼ºÀÚ°ü¸®ÀÚ
³¯Â¥ 2023-07-12 14:17:22
Á¦¸ñ Development of the Korea-Polyenvironmental Risk Score for Psychosis.
±â»ç ¸µÅ© http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958209/pdf/pi-2021-0328.pdf
Development_of_the_Korea-Polyenvironmental_Risk_Score_for_Psychosis..JPG

Abstract

Objective: Comprehensive understanding of polyenvironmental risk factors for the development of psychosis is important. Based on a review of related evidence, we developed the Korea Polyenvironmental Risk Score (K-PERS) for psychosis. We investigated whether the K-PERS can differentiate patients with schizophrenia spectrum disorders (SSDs) from healthy controls (HCs).

Methods: We reviewed existing tools for measuring polyenvironmental risk factors for psychosis, including the Maudsley Environmental Risk Score (ERS), polyenviromic risk score (PERS), and Psychosis Polyrisk Score (PPS). Using odds ratios and relative risks for Western studies and the "population proportion" (PP) of risk factors for Korean data, we developed the K-PERS, and compared the scores thereon between patients with SSDs and HCs. In addition, correlation was performed between the K-PERS and Positive and Negative Syndrome Scale (PANSS).

Results: We first constructed the "K-PERS-I," comprising five factors based on the PPS, and then the "K-PERS-II" comprising six factors based on the ERS. The instruments accurately predicted participants' status (case vs. control). In addition, the K-PERS-I and -II scores exhibited significant negative correlations with the negative symptom factor score of the PANSS.

Conclusion: The K-PERS is the first comprehensive tool developed based on PP data obtained from Korean studies that measures polyenvironmental risk factors for psychosis. Using pilot data, the K-PERS predicted patient status (SSD vs. HC). Further research is warranted to examine the relationship of K-PERS scores with clinical outcomes of psychosis and schizophrenia.

Keywords: Polyenvironmental risk factor; Prediction; Psychosis.

÷ºÎÆÄÀÏ


ÃÑ °Ô½Ã¹° 54 ÆäÀÌÁö 1/4

   
°Ô½ÃÆÇ ¸®½ºÆ®
¹øÈ£ Á¦¸ñ ÆÄÀÏ ÀÛ¼ºÀÚ ³¯Â¥ Á¶È¸¼ö
54 Associations between post-traumatic stress diso... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.21 192
53 Different topological patterns in structural co... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.18 195
52 Medications for Psychosis: Dopamine Blockers an... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.15 120
51 Validation of the Korean Version of the Communi... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.28 112
50 Predictors of full recovery in patients with ea... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.28 208
ÇöÀç±Û Development of the Korea-Polyenvironmental Risk... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 54
48 The factor structure and clinical utility of cl... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 51
47 Three-year outcomes and predictors for full rec... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 36
46 Associations of Clozapine Use With Psychosocial... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 114
45 DNA Methylation Profiles of the DRD2 and NR3C1 ... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 35
44 Comparison of clinical features and 1-year outc... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 36
43 Clozapine Optimization: A Delphi Consensus Guid... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 80
42 An automatic analysis framework for FDOPA PET n... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.04.18 193
41 Modeling Approach with Therapeutic Drug Monitor... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2022.09.14 220
40 The Relationship Between Frontostriatal Connect... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2022.07.25 225